Please turn JavaScript on
Find more feeds
Oncology News, Insights, Stories by OncoDaily icon

Oncology News, Insights, Stories by OncoDaily

Want to stay in touch with the latest updates from Oncology News, Insights, Stories by OncoDaily? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Oncology News, Insights, Stories by OncoDaily

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  29.1 / day

Message History

Vishwanath Sathyanarayanan: Oncology Leaders United at ASCO 2026


Vishwanath Sathyanarayanan, Senior Consultant Medical Oncologist and Academic Advisor at Apollo Hospitals, shared a post on LinkedIn: “Great interacting with oncology leaders, patient advocates, and global colleagues at the CPOEM Foundation […]

Read full story
Bridging the Gap Between Guidelines and Real-World Practice in Cardio-Oncology – Cardio-Oncology Bulletin


Cardio-Oncology Bulletin shared a post on LinkedIn: “Cardio-Oncology Bulletin | Practice Perspective Guidelines have significantly shaped the modern field of cardio-oncology, but one of the most important challenges remains their […]

Read full story
Voting Opens for the 2026 CancerX People’s Choice Award


CancerX shared a post on LinkedIn: “Vote for the 2026 CancerX People’s Choice Award! Innovation in oncology is only meaningful when it has the potential to create real-world impact for patients, providers, […]

Read full story
Myeloma Paper of the Day, June 3rd Suggested by Robert Orlowski


Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X: […]

Read full story
Robert Iannone: HER2 is an Oncogenic Driver Across a Range of Malignancies


Jazz Pharmaceuticals shared a post on LinkedIn: “HER2 is an oncogenic driver across a range of malignancies, including breast, gastrointestinal, lung and other cancers. This widespread presence makes it an […]

Read full story